Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth: a case-control study.

Manuck TA, Watkins WS, Esplin MS, Biggio J, Bukowski R, Parry S, Zhan H, Huang H, Andrews W, Saade G, Sadovsky Y, Reddy UM, Ilekis J, Yandell M, Varner MW, Jorde LB; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomics and Proteomics Network for Preterm Birth Research (GPN-PBR)..

BJOG. 2017 Jan 31. doi: 10.1111/1471-0528.14485. [Epub ahead of print]

PMID:
28139890
2.

Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.

Saccone G, Schoen C, Franasiak JM, Scott RT Jr, Berghella V.

Fertil Steril. 2017 Feb;107(2):430-438.e3. doi: 10.1016/j.fertnstert.2016.10.031.

PMID:
27887710
3.

[The use of progestatives for the prevention of spontaneous preterm birth].

Azria E.

J Gynecol Obstet Biol Reprod (Paris). 2016 Dec;45(10):1280-1298. doi: 10.1016/j.jgyn.2016.09.012. French.

PMID:
27776845
4.

Vaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis of randomized controlled trials.

Saccone G, Khalifeh A, Elimian A, Bahrami E, Chaman-Ara K, Bahrami MA, Berghella V.

Ultrasound Obstet Gynecol. 2016 Aug 22. doi: 10.1002/uog.17245. [Epub ahead of print] Review.

5.

17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis.

Combs CA, Schuit E, Caritis SN, Lim AC, Garite TJ, Maurel K, Rouse D, Thom E, Tita AT, Mol B; Global Obstetrics Network (GONet) collaboration..

BJOG. 2016 Apr;123(5):682-90. doi: 10.1111/1471-0528.13779. Review.

PMID:
26663620
6.

Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials.

Suhag A, Saccone G, Berghella V.

Am J Obstet Gynecol. 2015 Oct;213(4):479-87. doi: 10.1016/j.ajog.2015.03.031. Review.

PMID:
25797233
7.

17-alpha-hydroxyprogesterone caproate for maintenance tocolysis: a systematic review and metaanalysis of randomized trials.

Saccone G, Suhag A, Berghella V.

Am J Obstet Gynecol. 2015 Jul;213(1):16-22. doi: 10.1016/j.ajog.2015.01.054. Review.

PMID:
25659469
8.

Progestogen safety in multiple gestations: application of the Bradford Hill criteria.

O'Brien JM.

BJOG. 2015 Apr;122(5):610-4. doi: 10.1111/1471-0528.13277. No abstract available.

9.

Why the United States preterm birth rate is declining.

Schoen CN, Tabbah S, Iams JD, Caughey AB, Berghella V.

Am J Obstet Gynecol. 2015 Aug;213(2):175-80. doi: 10.1016/j.ajog.2014.12.011.

PMID:
25511243
10.

Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis.

Schuit E, Stock S, Rode L, Rouse DJ, Lim AC, Norman JE, Nassar AH, Serra V, Combs CA, Vayssiere C, Aboulghar MM, Wood S, Çetingöz E, Briery CM, Fonseca EB, Worda K, Tabor A, Thom EA, Caritis SN, Awwad J, Usta IM, Perales A, Meseguer J, Maurel K, Garite T, Aboulghar MA, Amin YM, Ross S, Cam C, Karateke A, Morrison JC, Magann EF, Nicolaides KH, Zuithoff NP, Groenwold RH, Moons KG, Kwee A, Mol BW; Global Obstetrics Network (GONet) collaboration..

BJOG. 2015 Jan;122(1):27-37. doi: 10.1111/1471-0528.13032. Review.

11.
12.

The rebirth of progesterone in the prevention of preterm labor.

Schmouder VM, Prescott GM, Franco A, Fan-Havard P.

Ann Pharmacother. 2013 Apr;47(4):527-36. doi: 10.1345/aph.1R281. Review.

PMID:
23535817
13.

Technique modifications for reducing the risks from amniocentesis or chorionic villus sampling.

Mujezinovic F, Alfirevic Z.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD008678. doi: 10.1002/14651858.CD008678.pub2. Review.

PMID:
22895978
14.

Reducing recurrent preterm births: best evidence for transitioning to predictive and preventative strategies.

Cypher RL.

J Perinat Neonatal Nurs. 2012 Jul-Sep;26(3):220-9. doi: 10.1097/JPN.0b013e3182611b9e. Review.

PMID:
22843004
15.
16.

Progesterone and preterm birth prevention: translating clinical trials data into clinical practice.

Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella..

Am J Obstet Gynecol. 2012 May;206(5):376-86. doi: 10.1016/j.ajog.2012.03.010. Erratum in: Am J Obstet Gynecol. 2013 Jan;208(1):86.

PMID:
22542113
17.

Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy.

Alfirevic Z, Stampalija T, Roberts D, Jorgensen AL.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD008991. doi: 10.1002/14651858.CD008991.pub2. Review.

PMID:
22513970
18.

Progestogens to prevent preterm birth in twin pregnancies: an individual participant data meta-analysis of randomized trials.

Schuit E, Stock S, Groenwold RH, Maurel K, Combs CA, Garite T, Spong CY, Thom EA, Rouse DJ, Caritis SN, Saade GR, Zachary JM, Norman JE, Rode L, Klein K, Tabor A, Cetingöz E, Morrison JC, Magann EF, Briery CM, Serra V, Perales A, Meseguer J, Nassar AH, Lim AC, Moons KG, Kwee A, Mol BW.

BMC Pregnancy Childbirth. 2012 Mar 15;12:13. doi: 10.1186/1471-2393-12-13.

19.

Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review.

Gunderson CC, Fader AN, Carson KA, Bristow RE.

Gynecol Oncol. 2012 May;125(2):477-82. doi: 10.1016/j.ygyno.2012.01.003. Review.

PMID:
22245711
20.

17α Hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.

Merlob P, Stahl B, Klinger G.

Reprod Toxicol. 2012 Jan;33(1):15-9. doi: 10.1016/j.reprotox.2011.10.017. Review.

PMID:
22120850
Items per page

Supplemental Content

Loading ...
Support Center